GlassScriptPhysician profile
John R Chapman
NPI 1811971377
$6,447.47
in general payments reported to CMS, 2019-2025
51 companies · $2,117 in 2025
The $2,117 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $215 · 2021: $1,220 · 2022: $605 · 2023: $803 · 2024: $868 · 2025: $2,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,534 · Travel and Lodging: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,533.53 |
| Travel and Lodging | $254.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $744.99 | 2021-2024 | Solesta |
| Edap Technomed INC | $667.01 | 2025 | |
| Antares Pharma, INC. | $374.60 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $347.38 | 2019-2025 | |
| Medtronic, INC. | $300.72 | 2022-2025 | Interstim |
| Janssen Biotech, INC. | $257.45 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Myovant Sciences INC. | $222.50 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $219.58 | 2020-2024 | Provenge |
| Sumitomo Pharma America, INC. | $210.58 | 2023-2025 | Orgovyx, Gemtesa |
| Bioprotect Medical, INC. | $203.17 | 2025 | Bioprotect Balloon Implant System |
| Calyxo, INC. | $196.92 | 2025 | Cvac Aspiration System |
| Procept Biorobotics Corporation | $183.22 | 2019-2025 | |
| Boston Scientific Corporation | $179.74 | 2020-2025 | Ams 700, Axonics, Rezum Generator |
| Myriad Genetic Laboratories, INC. | $165.03 | 2021-2025 | Prolaris, Myrisk |
| Astellas Pharma US INC | $157.81 | 2019-2024 | Xtandi |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.